
|Articles|October 15, 2018
Personalized Treatments Hold Promise for Lymphoma Patients
Author(s)Stephanie Stephens, MA
As lymphoma treatments become less cookie-cutter and more custom, the Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, shares how healthcare executives need to alter their approach to managing therapy regimens to increase cure rates and survivorship.
Advertisement
As lymphoma treatments become less cookie-cutter and more custom, the Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, shares how healthcare executives need to alter their approach to managing therapy regimens to increase cure rates and survivorship.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
The Shift in Star Ratings That Health Plans Can't Ignore
2
Fulton County Leaders Discuss Closing Health Gaps and Strengthening Behavioral Health Systems
3
Insights from the AMCP Nexus 2025 Meeting
4
Celiac Disease and Thyroid Disease in Adolescence Linked to the Development of Type 1 Diabetes in Adulthood
5

















































